Pain management in the hospitalized patient

Medical Clinics of North America

Volumn 86, Issue 4, 2002, Pages 771-795

  Li, Joseph Ming Wah ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BUPRENORPHINE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; DEZOCINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LEVACETYLMETHADOL; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; NALMEFENE; NALOXONE; NALTREXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PENTAZOCINE; PETHIDINE; PHENANTHRENE DERIVATIVE; PIPERIDINE DERIVATIVE; REMIFENTANIL; SUFENTANIL; UNINDEXED DRUG;

BIOTRANSFORMATION; BRADYCARDIA; DOCTOR PATIENT RELATION; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BINDING; DRUG CHOICE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG SOLUBILITY; HOSPITAL PATIENT; HUMAN; MEDICAL DECISION MAKING; PAIN; PAIN ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; RESPIRATION DEPRESSION; RESPONSIBILITY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; VISUAL ANALOG SCALE;

ACUTE DISEASE; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; GERIATRIC ASSESSMENT; HOSPICE CARE; HOSPITALIZATION; HUMANS; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 0036656625     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00025-1     Document Type: Review

References (53)

1. Stieg R, Lippe P, Shepard T. Roadblocks to effective pain treatment. Med Clin North Am 1999;83(3):809-19.
2. Schmitt P. Rehabilitation of chronic pain: a multi-disciplinary approach. J Rehabil 1985;51:72.
3. Gallagher R. Primary care and pain medicine: a community solution to the public health problem of chronic pain. Med Clin North Am 83(3):555-79.
4. Urban M, Gebhart G. Central mechanisms in pain. Med Clin North Am 1999;83(3):585-95.
5. Sorkin L, Wallace M. Acute pain mechanisms. Med Clin North Am 1999;79(2):213-25.
6. Bajwa Z, Shalmi C, Warfield C. Definition, pathogenesis, and evaluation of chronic pain. In Rose B, Rush J (founders). UpToDate online 10.1. 2002.
7. Crofford L, Casey K. Central modulation of pain perception. Med Clin North Am 1999;25(1):1-12.
8. Hough W, Bajwa Z, Warfield C. Epidemiology and pathogenesis of cancer pain. In: Rose B, Rush J (founders). UpToDate online 10:1. 2002.
9. McMahon SB. Mechanisms of cutaneous, deep and visceral pain. In: Wall P, Melzack R, editors. Textbook of pain. 3rd edition. New York: Churchill Livingstone; 1994. p. 129.
10. Cervero F, Laird J, Pozo M. Selective changes of receptive field properties of spinal Nociceptive neurons induced by noxious visceral stimulation in the cat. Pain 1992;51:335.
11. Portenoy R, Foley K, Inturrisi C. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990;43:273.
12. Hamill-Ruth R, Marohn M. Evaluation of pain in the critically ill patient. Crit Care Clin 1999;15(1):35-51.
13. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, editors. Handbook of pain assessment. New York: Guilford Press; 1992. p. 135-51.
14. Katz J, Melzack R. Measurement of pain. Surg Clin North Am 1999;79(2):231-48.
15. Melzack R, Katz J. Pain measurement in persons in pain. In: Wall PD, Melzack R, editors. Textbook of pain. 3rd edition. New York: Churchill Livingstone; 1994. p. 337-51.
16. Price DD, Harkins SW. Combined use of experimental pain and visual analogue scales in providing standardized measurement of clinical pain. Clin J Pain 1987;3:1-8.
17. Price DD, McGrath PA, Rafii A, et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
18. Choiniere M, Amsel R. A visual analogue thermometer for measuring pain intensity. J Pain Symptom Manag 1996;11:299-311.
19. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1998;14:9-17.
20. Volles D, McGory R. Pharmacokinetic considerations. Crit Care Clin 1999;15(1):55-72.
21. Benet L, Sheiner L. Pharmacokinetics: the dynamics of drug absorption, distribution and elimination. In: Gilman AG, Goodman LS, Rall TW, et al, editors. The pharmacological basis of therapeutics. 7th edition. New York: Macmillan Publishing Co.; 1985. p. 3-33.
22. McGory R. Pharmacokinetic and pharmacodynamic conerns in the critically ill. In: Hamill RJ, Rowlingson RC, editors. Handbook of critical care pain management. New York: McGraw-Hill, Inc.; 1994. p. 85.
23. Bentley JB, Finley JH, Humphrey LR, et al. Obesity and alfentanil pharmacokinetics. Anesth Analg 1983;62:251.
24. Bentley JB, Borel JD, Gillespie TJ, et al. Gentanyl pharmacokinetics in obese and nonobese patients. Anesthesiology 1981;55:A177.
25. Bovill JG. Pharmacokinetics of opioids. In: Bowdle TA, Horita A, Kharasch ED, editors. The pharmacologic basis of anesthesiology. New York: Churchill Livingstone; 1994. p. 37-81.
26. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83(3):761-84.
27. Austrup ML, Korean G. Analgesic agents for the postoperative period. Surg Clin North Am 1999;79(2):253-71.
28. Forrest J. Pharmacology of opioids. In: Acute pain: pathophysiology and treatment. Grimbsy, Ontario, Canada: Manticore Publishers; 1998. p. 75-98.
29. Offermeier J, Van Rooyen JM. Opioid drugs and their receptors. South Afr Med J 1984;66:299-305.
30. Bailey PL. Clinical Pharmacology and Applications of Opioid Agonists. In: Bowdle TA, Horita A, Kharasch ED, editors. The pharmacologic basis of anesthesiology. New York: Churchill Livingstone; 1994. p. 83-117.
31. Campora E, Merlini L, Pace M, et al. The incidence of narcotic induced emesis. J Pain Symptom Manage 1991;6:428-30.
32. Pappagallo M. Aggressive pharmacologic treatment of pain. Rheum Clin of North Am 1999;25(1):193-210.
33. Sandler AN. Clinical pharmacology and applications of spinal opioids. In: Bowdle TA, Horita A, Kharasch ED, editors. The pharmacologic basis of anesthesiology. New York: Churchill Livingstone; 1994. p. 149-78.
34. Stoelting RK. Opioid agonists and antagonists. In: Pharmacology and physiology in anesthetic practice. 2nd edition. Philadelphia: JB Lippincott; 1991. p. 70-101.
35. Pantilat S. Managing pain in the hospitalized patient. In: NAIP Fifth Annual Meeting Course Syllabus. Philadelphia: NAIP; 2002. p. 109-21.
36. Cherny N, Foley K. Nonopioid and opioid analgesic pharmacotherapy of cancer pain. Hematol Onc Clin of North Am 1996;10(1):79-97.
37. Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. NEJM 2001;345(25):1809-17.
38. Loscalzo M. Psychological approaches to the management of pain in patients with advanced Cancer. Hematol Oncol Clin North Am 1996;10:139.
39. Simon L. Overview of selective COX-2 inhibitors. In: Rose B, Rush J (founders). UpToDate online 10.1. Electronic media: Wellsley, MA. 2002.
40. Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 2000;35:937.
41. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954.
42. Power I, Barratt S. Analgesic agents for the postoperative period. Surg Clin North Am 1999;79(2):275-89.
43. Bajwa ZH, Sami N, Ho C. Antiepileptic drugs in the treatment of neuropathic pain. In: Rose B, Rush J (founders). UpToDate Online, 10.1; 2002.
44. Portenoy RK. Adjuvant analgesic agents. Heme Onc Clin of North Am 1996; 10(1):103-17.
45. Savage S, Covington EC, Heit HA, et al. Definitions related to the use of opioids for the treatment of pain. In: Consensus document from the American Academy of Pain Medicine (Glenview, IL), The American Pain Society (Glenview, IL) and the American Society of Addiction Medicine (Chevy Chase, MD); 2001.
46. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. 1995;274:1870.
47. Hough SW, Bajwa ZH, Warfield CA. Nonpharmacologic therapy of cancer pain. In: Rose B, Rush J (founders). UpToDate online 10.1. 2002.
48. Breitbart W. Psychiatric management of cancer pain. Cancer 1989;63:2336.
49. Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline No. 9. AHCPR Publication No. 94-0592. Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service: Rockville (MD); March 1994.
50. Rhiner M, Ferrell BR, Ferrell BA, et al. A structured non-drug intervention program for Cancer pain. Cancer Pract 1993;1:137.
51. Lehman JF, deLateur BJ. Ultrasound shortwave, microwave, laser, superficial heat, and cold in the treatment of pain. 3rd edition. In: Wall PD, Melzack R, editors. Textbook of pain. Edinburgh: Churchill Livingstone; 1994. p. 1237.
52. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:69.
53. Dahl JL, Berry P, et al. Pain assessment and management: an organizational approach. Joint Commission on Accreditation of Healthcare Organizations publication. Oakbrook Terrace: JCAHO. 2000.